Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Philips
Philips - Credit: alexeynovikov / DepositPhotos - License: DepositPhotos
Business
Philips
Exor
healthcare technology
Roy Jakobs
Feike Sijbesma
John Elkann
Monday, 14 August 2023 - 09:12

Share this article:

Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window

Fiat’s Agnelli family snaps up 15% stake in Philips

The Italian investment firm Exor has bought 15 percent of Philips’ shares, the two companies announced on Monday. The investor and medical tech company both stressed that Exor has no intention to interfere with Philips’ leadership and strategy. In exchange for long-term investment, Exor may nominate one member to Philips’ supervisory board.

According to ANP, the 15 percent Philips shares cost Exor around 2.6 billion euros and made the Italian investment company the largest shareholder of the healthcare technology group in one swoop. Exor was founded by the Agnelli family and is mainly known for being the founder of the Fiat car factory, the owner of the football club Juventus, and the largest shareholder in sports car manufacturer Ferrari.

Philips stressed that Exor’s investment in Philips will not result in share dilution. Exor has no immediate plans to buy more Philips shares, but the agreement states that the investor can increase its interest to up to 20 percent of Philips’ outstanding ordinary share capital in the future.

Exor said it fully supports Philips’ leadership and strategy to focus on medical technology. “The path of change taken by Philips in recent years has created a company that combines two areas - healthcare and technology - to which we are committed,” Exor CEO John Elkann said.

Philips CEO Roy Jakobs said that Exor’s investment and long-term outlook fit well into the healthcare tech company’s strategy. “With our market leadership positions and people-centric innovation capabilities, Philips is well positioned to deliver on our purpose to improve the health and well-being of people, creating value for all stakeholders.”

Feike Sijbesma, chairman of Philips’ supervisory board, pointed out Exor’s “successful track record and clear strategy to grow and develop in healthcare technology.” According to him, “Exor’s substantial investment underlines their confidence in Philips’ transformation into a healthcare technology company and its growth and value potential.”

More like this

Image
Philips
Philips books €897 million profit in 2025; First annual profit since 2021
Image
Philips
Philips raises profit forecast after tariff impact drops
Image
Philips
Philips expects trade war tariffs to cost it up to €300 million
Image
Philips
Philips suffered €698 million loss last year, mainly over $1.1 billion recall settlement
Make NL Times your top Google source

Follow us:

Latest stories

  • Third regional heatwave hits Netherlands, breaking 2006 record
  • Dutch short track skater Sven Roes returns home after disappearing earlier this summer
  • Suspect in ABN Amro worker's fatal stabbing also harassed four other women
  • Dutch doctors report rise in lung and heart illnesses among vapers
  • PostNL ends next-day standard letter delivery; Priority mail now costs 3.95 euros

Top stories

  • Suspect in ABN Amro worker's fatal stabbing also harassed four other women
  • New public transport strikes looming as contract talks stall
  • Explosion at apartment complex in Woerden; Dozens of homes evacuated
  • Dutch SMEs investing less due to high costs and inconsistent gov't policy: study
  • Man severely beaten after Amersfoort Pride; Police probe anti-LGBTQ+ motive

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content